Clinical Applications (heavy metal poisoning, iron overload, Wilson’s disease)
Start with the big picture
The lesson connects the basic mechanism of chelation—metal binding followed by urinary or biliary excretion—to clinical treatment choices. It surveys agents used for lead, arsenic, mercury, iron, and copper-related conditions, including Wilson’s disease, and compares their routes of administration and notable risks. Clinical considerations include early treatment in acute heavy-metal exposure, maintaining hydration and urine flow, avoiding competing minerals or supplements during treatment, and using laboratory monitoring to guide therapy. The preview introduces these principles; the full lesson develops the individual agents and their roles in greater detail.
What you'll learn
- Explain how chelators bind metals and support their elimination.
- Distinguish chelating agents used for lead, arsenic, mercury, iron, and copper-related conditions.
- Identify notable administration routes and safety concerns for major chelators.
- Describe clinical considerations that inform chelation treatment and monitoring.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
